International Journal of Cancer · 1974 · 125 citations · 21 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunogeneticsTumor ImmunologyCancer RiskImmuno-oncology BiomarkersMalignant NeoplasmsNasopharyngeal CancerTumor AntigensTumor-associated AntigensCancer AntigensCancer Germline AntigensHla Antigen ExpressionImmunogenetic Risk StratificationImmunogenetic SusceptibilityStatistical Significance TestingTumor Antigen Identification
Abstract This paper reports the results of two studies which compared the HL‐A profile of predominantly Chinese patients with nasopharyngeal carcinoma to that of suitably chosen controls. The first study demonstrated a significant increase in the proportion of NPC patients in whom less than two second locus antigens were detectable. The second confirmatory study also demonstrated the same phenomenon at a high level of statistical significance, and furthermore showed a significant elevation among the NPC patients of the frequency of HL‐A2. Both the elevation of the HL‐A2 frequency and the deficit of detectable second locus antigens remained significant after application of the most conservative correction factor for the number of antigens investigated. Various sources of bias have been considered and appear not to have appreciably influenced the results. The results are discussed in terms of the postulated genetic basis of the elevated risk for NPC among the Chinese.
21
Histocompatibility Testing 1965
J. Wayne Streilein · JAMA · 1966 · 1.3K citations
HISTOCOMPATIBILITY TESTING, 1972
Ren Ee Chee · The Medical Journal of Australia · 1974 · 1.2K citations
Life Sciences, Genetics, Immunology +17
The pathology and nomenclature of Hodgkin's disease.
Talvalkar Gv · PubMed · 1972 · 762 citations